POTENTIAL APPROACHES FOR REDUCING AMYLOID β PRODUCTION.

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Alzheimer's disease (AD) is a neurodegenerative disorder characterized by mitochondrial dysfunction, synaptic defects, and cognitive decline.
• Amyloid beta (Aβ) accumulation in synapses and mitochondria is a key pathological event in AD neurons.
• The exact pathogenesis of AD remains incompletely understood, hindering effective treatment development.

Purpose of the Study:

• To review recent advancements in understanding amyloid beta-induced mitochondrial defects in Alzheimer's disease.
• To explore potential therapeutic strategies targeting amyloid beta for AD treatment.

Main Methods:

• Literature review of current research on Alzheimer's disease pathogenesis.
• Analysis of studies investigating amyloid beta's role in mitochondrial dysfunction.
• Examination of Aβ-targeting therapeutic approaches.

Main Results:

• Amyloid beta accumulation significantly contributes to synaptic and mitochondrial deficits in AD.
• Current treatments primarily focus on alleviating symptoms, with limited disease-modifying options.
• Hypothesis-based drugs targeting amyloid precursor protein show potential for managing psychological and behavioral symptoms.

Conclusions:

• Targeting amyloid beta represents a promising avenue for Alzheimer's disease therapy.
• Further research into Aβ-induced mitochondrial dysfunction is crucial for developing effective treatments.
• Developing drugs that prevent and treat AD requires a deeper understanding of its complex pathogenesis.